Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 2

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Conditions

Lymphedema 2Neoplasms 1Menorrhagia 1

Interventions

Manual Lymphatic Drainage 10Exercise 10Low-Level Light Therapy 6Standard of Care 4Physical Therapy Modalities 4Exercise Therapy 4Acupuncture Therapy 4Resistance Training 3Methods 3Indocyanine Green 3Compression Bandages 3pycnogenols 2Yoga 2Technetium Tc 99m Sulfur Colloid 2Radiotherapy 2Pentoxifylline 2Lipectomy 2High-Energy Shock Waves 2Early Intervention, Educational 2Control Groups 2Bupivacaine 2Bevacizumab 2specific substance maruyama 1pirfenidone 1pazopanib 1carbohydrate-deficient transferrin 1Wound Closure Techniques 1Weights and Measures 1Weight Reduction Programs 1Vitamin E 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Lymphedema × pycnogenols × Clear all
NCT00214032 2015-10-05

Pycnogenol for the Treatment of Lymphedema

University of Wisconsin, Madison

Phase 2 Completed
2 enrolled

Lymphedema

NCT00064857 2008-04-22

Pycnogenol for the Treatment of Lymphedema of the Arm in Breast Cancer Survivors

National Center for Complementary and Integrative Health (NCCIH)

Phase 2 Completed
26 enrolled

Lymphedema, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡